Cardio Diagnostics offers two prescription-only blood tests that you can access via our telemedicine partner.
Coronary heart disease (CHD) is the leading cause of death in the U.S., responsible for nearly 1 in every 5 deaths. Each year, more than 800,000 Americans experience a heart attack, and for many, it is the first sign of underlying disease.
While CHD generally results from a build up of plaque in the arteries of the heart, CHD and heart attacks can also occur when the arteries aren't severely blocked.
One example is Ischemia with No Obstructive Coronary Artery disease (INOCA). INOCA is particularly common in women and happens when blood flow to the heart is reduced without major plaque build-up or visible blockages. Plaque build-up and the presence of traditional risk factors like high blood pressure, diabetes, or high cholesterol are important to know, but they don't explain everything about heart disease.
Complete a pretest questionnaire to see which Cardio Diagnostics test may be right for you.
This tool will ask you up to 5 questions about your age and health history. Based on your answers, we'll point you to the test that best fits your profile.
cardiovascular disease remains the leading cause of death in the US
of cardiovascular diseases, including heart attacks, are preventable
heart attacks are silent and occur without warning
Your DNA is your genetic blueprint, the code you are born with. But genetics accounts for less than 20% of heart disease risk.
The larger influence comes from epigenetics, which is how your environment, lifestyle, and everyday experiences affect how your DNA is expressed. This is in part why heart disease is largely preventable. Epigenetics acts like the switchboard that controls whether certain genes linked to heart disease are turned on or off.
An estimated 80% of cardiovascular disease is preventable. That means your heart health risk isn't fixed at birth. It shifts and changes over time, depending on what you do and the world around you. By combining epigenetics and genetics with artificial intelligence, our tests deliver a more complete and precise view of your heart health.
Epi+Gen CHD™ is a clinical test that assesses the three-year risk of experiencing a coronary heart disease event, including a heart attack.
Epi+Gen CHD™ may be right for you if:
Epi+Gen CHD™ is $315
FSA/HSA Eligible
PrecisionCHD™ is a clinical test that aids in the diagnosis and management of coronary heart disease, the most common type of heart disease and the primary cause of heart attacks.
PrecisionCHD™ may be right for you if:
PrecisionCHD™ is $765
FSA/HSA Eligible
The cost of the test may be reimbursed by your FSA/HSA, contact your individual FSA/HSA for more information.
Our tests must be prescribed by a licensed healthcare provider. Request your at-home test through our independent telemedicine partner.
After a healthcare provider orders the test, you'll receive an at-home kit with materials to collect and ship your sample.
Results will be ready within 10 business days of your sample arriving at our lab. The healthcare provider will share results and is available for a follow up consultation.
By combining epigenetics with AI, our tests go beyond traditional tests to measure your unique molecular biology.
Our blood tests do not require fasting or exposure to radiation that could increase cancer risk.
Our technology combines epigenetics, genetics, and AI to more comprehensively assess heart health even in the absence of risk factors.
Our tests are clinically validated, backed by peer-reviewed publications, and have high sensitivity and specificity.
Patients can request a test via our telemedicine partner and collect their sample at home. Once results are ready, the patient can complete a virtual consult with a provider to better understand what their results mean.
For questions about our tests, please contact our team:
